Transdermal testosterone delivery systems

Endocrinologist

Volumn 6, Issue 3, 1996, Pages 207-213

  Cofrancesco Jr , Joseph ^a   Dobs, Adrian S ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN METABOLISM; CIRCADIAN RHYTHM; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MALE; REVIEW; SEXUAL FUNCTION; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029995596     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199605000-00007     Document Type: Review

References (15)

1. Nieschlag E, Behre HM (editors): Testosterone: Action, Deficiency, Substitution. Berlin, Springer-Verlag 1990.
2. Synder PJ: Clinical use of androgens. Ann Rev Med 1984; 35: 207-17.
3. Resko JA, Eik-nes KB: Diurnal testosterone levels in peripheral plasma of human male subjects. J Clin Endocrinol Metab 1966; 26: 573-6.
4. Bhasin S: Androgen treatment of hypogonadal men. J Clin Endocrinol Metab 1992; 74(6): 1221-5.
5. Wilson JD, Griffin JE, Russell DW: Steroid 5 α-reductase 2 deficiency. Endocr Rev 1993; 24(5): 577-93.
6. Belanger A, Candas B, Dupont A, et al.: Changes in serum concentrations of conjugated and unconjugated steroids in 40 to 80 young men and women. J Clin Endocrinol Metab 1994; 79: 1086-90.
7. Bremner WJ, Fitiello MV, Prinz PN: Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983; 56(6): 1278-81.
8. Davidson JM, Camargo CA, Smith ER: Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab 1979; 48(6): 955-8.
9. Berti JJ, Lipsky JJ: Transcutaneous drug delivery: a practical review. Mayo Clin Proc 1995; 70: 581-6.
10. Testoderm® Testosterone Transdermal System, Product Monograph Data on file. ALZA Corporation, Palo Alto, CA.
11. Cunningham GR, Cordero E, Thornby JL: Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA 1989; 261(17): 2525-30.
12. Place VA, Atkinson L, Prather DA, Trunnell, Yates FE: Transdermal testosterone replacement through genital skin. In Testosterone: Action, Deficiency, Substitution, edited by Nieschlag E, Behrs HM, pp. 165-181, Berlin, Springer-Verlag 1990.
13. SmithKline Beecham, Product Monograph Data on file. SmithKline Beecham, Philadelphia, PA.
14. Meikle AW, Arver S, Dobs AS, et al.: Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J Clin Endocrinol Metab 1992; 74: 623-8.
15. Meikle AW, Arver S, Dobs AS, Sanders SW, Rajaram L, Mazer NA: Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site. J Clin Endocrinol Metab (in press).